Loading summary
A
Welcome to Thoughts on the Market. I'm Robert Davies, Morgan Stanley's head of the European Medtech research team. Today I wanted to take you behind the scenes to show you how AI is revolutionizing our approach to medical diagnostics via smart imaging. It's Thursday, December 5th at 10:00am in Boston. When was the last time you needed to get an X ray, a CT scan or an ultrasound? Depending on where you live, your wait time could be as long as a month. Medical diagnostics through imaging is facing enormous challenges right now. Population growth, rising longevity and intensifying chronic disease burdens are driving ever increasing volumes of medical scans. In the US alone, CT scan volumes have quadrupled since 1995. So what is the impact of this? Imagine a radiologist interpreting a CT or MRI image every three to four seconds during an eight hour workday. This is the current pace needed to meet soaring demand. At the same time, the US population is getting older and a growing number of people are signing up for Medicare. Healthcare costs are continually rising. Total US healthcare spend is now hitting 4.5 trillion. That's nearly 20% of total US GDP. On top of that, patients need fast, accurate diagnosis. But long wait times often mean patients don't get the diagnostic done in time, or sometimes not at all. All of this indicates that more and more stress is being placed on the hospital system each year in terms of diagnostic imaging. Smart imaging uses AI tools to improve image processing and workflows to enhance traditional image gathering, processing and analysis. It sits at the intersection of longevity and tech diffusion, two of Morgan Stanley Research's big themes for 2024, and it can help solve these acute demand challenges. In fact, AI is already transforming the $45 billion diagnostic imaging market. AI driven smart imaging integrates into the diagnostic imaging workflow at multiple stages, from preparation and planning all the way to image processing and interpretation. The primary benefits of using AI are twofold. Firstly, it enhances image quality, which ensures more accurate diagnosis. And secondly, it improves the speed, efficiency and overall comfort of the patient journey. At the same time, AI effectively acts as a second set of eyes for the radiologist, often surpassing human accuracy and pattern recognition. That's crucial in reducing diagnostic errors, a problem costing the US healthcare system an estimated $100 billion annually at the moment. In addition to minimizing misdiagnosis, AI is not only capable of identifying the primary disease, but also registering any potential secondary diseases. Otherwise, this isn't normally a priority for the radiologist, who's only able to spend three to four seconds looking at any individual image. But it's a potentially life saving benefit for using smart imaging applications. So how does AI fit into the clinical setting? There are multiple stages to the diagnostic imaging workflow and AI can play a role across the entire value chain from preparing a patient scan to processing the images and finally aiding in the diagnosis, reporting and treatment planning. Radiology is currently dominating the FDA list of AI machine learning enabled medical devices and when we look at the broader economic implications it's clear smart imaging represents a pivotal development in healthcare technology that has broad implications for healthcare costs, quality of care and better healthcare outcomes. Thanks for listening. If you enjoy the show, please leave us a review wherever you listen and share thoughts on the market with a friend or colleague today.
B
The preceding content is informational only and based on information available when created. It is not an offer or solicitation nor is it tax or legal advice. It does not consider your financial circumstances and objectives and may not be suitable for.
Podcast Summary: "AI as a Second Set of Eyes"
Thoughts on the Market
Host: Morgan Stanley
Episode Title: AI as a Second Set of Eyes
Release Date: December 5, 2024
Host Speaker: Robert Davies, Head of European Medtech Research, Morgan Stanley
In the episode titled "AI as a Second Set of Eyes," Robert Davies delves into the transformative role of Artificial Intelligence (AI) in the realm of medical diagnostics, particularly focusing on smart imaging technologies. Released on December 5, 2024, this episode addresses the escalating challenges faced by the medical imaging sector due to increasing demand driven by population growth, longer lifespans, and a rise in chronic diseases.
Davies sets the stage by highlighting the current state of medical diagnostics:
“Medical diagnostics through imaging is facing enormous challenges right now. Population growth, rising longevity and intensifying chronic disease burdens are driving ever increasing volumes of medical scans.” (00:45)
He underscores the urgency of the situation by noting that in the United States alone, the number of CT scans has quadrupled since 1995, placing immense pressure on radiologists who must interpret scans at a relentless pace.
Davies paints a vivid picture of the strain on the healthcare system:
“Imagine a radiologist interpreting a CT or MRI image every three to four seconds during an eight-hour workday. This is the current pace needed to meet soaring demand.” (01:10)
This relentless pace not only increases the risk of diagnostic errors but also contributes to prolonged wait times for patients needing critical diagnoses. The financial implications are staggering, with total US healthcare spending reaching $4.5 trillion, constituting nearly 20% of the nation's GDP.
Transitioning to the solution, Davies introduces AI-driven smart imaging as a pivotal advancement capable of mitigating these challenges. He explains that smart imaging leverages AI tools to enhance various stages of the imaging workflow, from preparation and planning to image processing and interpretation.
“Smart imaging uses AI tools to improve image processing and workflows to enhance traditional image gathering, processing and analysis.” (01:55)
The primary benefits highlighted include:
Enhanced Image Quality: AI algorithms can refine image clarity and detail, enabling more accurate diagnoses. This improvement is crucial for detecting subtle abnormalities that might be missed by human eyes.
Improved Speed and Efficiency: By automating time-consuming tasks, AI accelerates the diagnostic process, reducing wait times and increasing the throughput of medical facilities.
Enhanced Patient Comfort: Streamlining workflows not only benefits healthcare providers but also enhances the patient experience by minimizing delays and ensuring timely interventions.
A significant focus of the episode is on AI's role as a "second set of eyes" for radiologists. Davies emphasizes that AI can surpass human accuracy and pattern recognition capabilities, thereby playing a critical role in minimizing diagnostic errors—a problem that currently costs the US healthcare system an estimated $100 billion annually.
“AI effectively acts as a second set of eyes for the radiologist, often surpassing human accuracy and pattern recognition.” (02:30)
This augmentation is particularly important given that radiologists are required to spend only three to four seconds on each image. AI not only aids in identifying primary diseases but also has the capacity to detect secondary conditions that might otherwise go unnoticed due to time constraints.
Davies provides an in-depth look at how AI integrates into the clinical setting, outlining its presence across the entire diagnostic imaging value chain:
“AI can play a role across the entire value chain from preparing a patient scan to processing the images and finally aiding in the diagnosis, reporting and treatment planning.” (02:50)
Davies also notes that radiology is at the forefront of AI integration, dominating the FDA's list of AI-enabled medical devices. This leadership position underscores the significant impact AI is already having on the diagnostic imaging market, valued at $45 billion.
Beyond the immediate benefits to diagnostics, Davies explores the broader economic implications of smart imaging. AI-driven advancements in medical imaging are poised to be a cornerstone in controlling rising healthcare costs while simultaneously improving the quality of care and patient outcomes.
“Smart imaging represents a pivotal development in healthcare technology that has broad implications for healthcare costs, quality of care and better healthcare outcomes.” (03:05)
In wrapping up the discussion, Davies reiterates the transformative potential of AI in addressing the critical challenges facing medical diagnostics. By enhancing image quality, speeding up diagnostic processes, and reducing errors, AI stands to revolutionize the healthcare landscape, making it more efficient, cost-effective, and capable of delivering better patient outcomes.
“AI is already transforming the $45 billion diagnostic imaging market.” (02:15)
As healthcare systems worldwide grapple with increasing demands, AI-driven smart imaging offers a promising solution that aligns with broader themes of longevity and technological diffusion, two key focus areas for Morgan Stanley Research in 2024.
Note: The episode concludes with a standard disclaimer emphasizing that the content is informational and not intended as financial, legal, or tax advice.